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Identification of the conditions that Complementary Medicine 1 




A gluten free diet (GFD) is indicated for the medical management of coeliac disease as well 6 
as gluten ataxia, dermatitis herpetiformis, and wheat allergy. Complementary medicine 7 
practitioners (CMPs) recommend removing gluten from the diet, but it is not known what 8 
symptoms or conditions they recommend gluten free diets for. The aim of this study is to 9 
describe for what conditions Australian naturopaths, Western herbalists and nutritionists (non-10 
dietetic) recommend a gluten free diet.  11 
 12 
Methods 13 
This was a sub-group analysis nested within a cross-sectional survey of practitioners recruited 14 
through the PRACI practice-based research network and relevant professional associations. 15 
A 40-item survey collected information on sociodemographic characteristics, practice and 16 
professional characteristics and specific questions on gluten related disorders between 17 
February and August 2017. Data was described using frequencies and percentages along 18 
with one-way ANOVA to determine group differences. 19 
Results 20 
One hundred and forty-five complementary practitioners responded to the survey. The 21 
gastrointestinal conditions most frequently prescribed a GFD for were non-coeliac gluten 22 
sensitivity (99%), medically diagnosed coeliac disease (95.2%), inflammatory bowel disease 23 
(73.1%) and irritable bowel syndrome (60%). The most frequently prescribed GFDs for extra-24 
intestinal conditions were skin conditions (60%), children with developmental disorders 25 
(53.1%), mental health conditions (46.2%) and weight management.  26 
 27 
Discussion 28 
Results suggest that given the broad application of GFDs by CMPs, there may be therapeutic 29 
benefits for conditions other than known gluten related disorders. However, in the absence of 30 
appropriate investigations for gluten related disorders, the recommendation and positive 31 
response to a GFD may be inadvertently treating an undiagnosed gluten related disorder. In 32 
addition, a GFD may also be inadvertently managing other unknown intolerances that require 33 
different clinical management.  34 
 35 
Conclusion 36 
2 | P a g e  
 
This research highlights the need for further investigation into the potential benefits resulting 37 
from prescribing GFDs for conditions where there is no established evidence for the exclusion 38 
of dietary gluten.  39 
 40 
 41 
Keywords: Complementary Medicine Practitioners; Naturopath; Nutrition; Gluten Free Diet; 42 
Coeliac Disease; Conditions 43 
 44 




Excluding gluten containing foods from the diet has become a popular choice by people in 3 
Australia. The main drivers of this trend are thought to be associated with the popular belief 4 
that ‘gluten avoidance’ is a healthier way to eat [1], coupled with extensive marketing in 5 
Australia and throughout other parts of the world. In addition, food industry promoted gluten 6 
free products were estimated to yield $1,328 million USD in 2016 [2]. Nevertheless, strict 7 
adherence to a gluten free diet (GFD) is essential for the management of coeliac disease and 8 
plays a role in the treatment of gluten related disorders including, gluten ataxia, non-coeliac 9 
gluten sensitivity (NCGS), wheat allergy [3], and dermatitis herpetiformis [4].  10 
 11 
Coeliac disease (CD) is an autoimmune disorder resulting from an interaction between dietary, 12 
genetic and immunological factors. It is estimated that 1.2% of Australian men and 1.9% of 13 
Australian women are living with coeliac disease [5], with an estimated 80% of cases 14 
remaining undiagnosed [6]. Coeliac disease can present at any age with protean presentations 15 
[7] [8]. NCGS is a disorder that exhibits similar symptoms to coeliac disease with the absence 16 
of specific biological markers of disease [9]. People with NCGS have symptom relief following 17 
removal of dietary gluten. The true prevalence of NCGS is not known but estimates suggest it 18 
affects between 0.6 to 6% of the Australian population [10].  19 
 20 
The medical requirement for a GFD only makes up a small portion of the 20% of Australians 21 
reported to be following a GFD [11]. There has been a number of studies that have identified 22 
the potential benefits of following a GFD in conditions other than gluten related disorders [1]. 23 
However, it is proposed that many people who are receiving symptomatic relief from a GFD 24 
are doing so because of the inadvertent removal of fermentable carbohydrates or specific 25 
antigenic wheat proteins [12]; therefore, it is unnecessary to exclude all gluten containing 26 
grains [1]. 27 
 28 
It has been reported that the majority of GFDs are self-prescribed, or prescribed by a 29 
complementary medicine practitioner (CMP) often prior to the appropriate exclusion of gluten 30 
related disorders [11]. In addition, it has been found that people with non-coeliac gluten 31 
sensitivity (NCGS) are less receptive to conventional medicine and more receptive to 32 
complementary medicine [13]. To our knowledge, there have been no studies exploring what 33 
conditions CMPs recommend GFDs for. Therefore, this study aimed to describe the health 34 
conditions for which Australian naturopaths, Western herbalists and nutritionists (non-dietetic) 35 
recommend a gluten free diet.  36 
 37 





A sub-group analysis of a cross-sectional survey of Australian naturopaths, nutritionists 41 
(non-dietetic) and Western herbal medicine practitioners.  42 
Participants 43 
The sample population comprised of 145 complementary medicine practitioners (i.e. 44 
naturopaths, nutritionists, Western herbalists) who were currently practicing in Australia and 45 
reported prescribing gluten free diets to patients. Due to the recruitment method we were 46 
unable to calculate a response rate for this study. 47 
Measures 48 
This GFD sub-study included items that measured sociodemographic characteristics such as 49 
age, gender, and practice location. Data on practice and professional characteristics were also 50 
collected through items measuring professional education (level of education and length of 51 
time since highest qualification) and length of time in full-time or part-time practice. Questions 52 
were also asked specifically focused on gluten related disorders including clinical 53 
management, and practice behaviours.  54 
Data collection 55 
The survey was administered electronically between February and August 2017 through the 56 
SurveyGizmo online platform. Recruitment was conducted through the Practitioner Research 57 
and Collaboration Initiative PRACI practice-based research network. The study was also 58 
advertised to practitioners through professional associations including the Australian Natural 59 
Therapists Association and the Naturopaths and Herbalists Association of Australia. 60 
Data analysis 61 
Data were analysed in Stata14® statistical analysis software. Binary variables were created 62 
for the items: medically diagnosed with coeliac disease, gastrointestinal conditions 63 
recommend for gluten diets, and extra-intestinal conditions recommend for GFDs (e.g. 64 
respiratory disorders). Descriptive analysis (frequency and percentage) was conducted for 65 
age, gender, coeliac disease diagnosis, location, level of qualification, years since highest 66 
qualification, years as a CMP, recommendations of GFDs for selected conditions,  67 
communication styles, how well the communication was received, reason for not 68 
communicating with a general practitioner, further education choices and knowledge on gluten 69 
free disorder questions.  70 
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Chi square analysis was used to test associations between age, level of qualification, years in 71 
practice, type of gastrointestinal condition, type of extra-intestinal conditions, and 72 
recommending a GFD. Cramer’s V was used to determine the strength of the associations. 73 
 74 
Ethics 75 
Ethical approval for the study was provided by The Human Research Ethics Committee of the 76 
University of Sydney (HREC-approval number 2017/139), and the PRACI steering committee 77 
approved the use of the PRACI database for recruitment (PRACI approval number 20170110). 78 
 79 
Results 80 
Demographic and practice characteristics 81 
 82 
Question 1 of the survey asked participants if they prescribed GFDs in practice. There were 83 
145 practitioners who answered yes to this question and completed the survey. Of these 84 
practitioners, 7.6% (n=11) had been medically diagnosed with CD for 10.3 ± 2.46 years. 99.3% 85 
(n=144) of practitioners recommended a GFD within their practice, and 50% (n=73) personally 86 
followed a GFD.  87 
 88 
The sample was mainly comprised of females (92.4%), with the majority of participants located 89 
in Victoria (30.5%), New South Wales (29.8%), and Queensland (26.4%). Sixty-five percent 90 
have attained a Bachelor degree with 13% possessing post-graduate qualifications. The 91 
majority of practitioners have achieved their highest qualification in the last 10 years (58%) 92 
and have been in practice as CMP for less than 10 years (58%). See Table 1 a summary of 93 
demographic information.  94 
 95 
INSERT TABLE 1 96 
 97 
Health conditions that CM practitioners recommend a gluten free diet for   98 
 99 
The gastrointestinal conditions CMPs recommended a GFD for can be seen Table 2. Medically 100 
diagnosed coeliac disease was the condition with the most frequent recommendations for a 101 
GFD (95.2%), followed by patients medically diagnosed with NCGS (99%), inflammatory 102 
bowel disease (73%), and irritable bowel syndrome (60%).  103 
 104 
Of those who recommended a GFD to patients who were diagnosed with NCGS, there was a 105 
medium statistically significant association with CM practitioner qualifications (p=0.001) and 106 
years in practice (p=0.013). Practitioners with higher qualifications or with more years in 107 
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practice were more likely to recommend a GFD to patients with NCGS. There was also a 108 
medium significant association between level of qualification and recommending a GFD to 109 
medically diagnosed irritable bowel syndrome (p=0.046). Practitioners with a bachelor degree 110 
or higher qualification were more likely to recommend a GFD for NCGS, while practitioners 111 
with a bachelor degree or lower were more likely to recommend a GFD for IBS.  112 
 113 
INSERT TABLE 2 114 
 115 
Extra-intestinal conditions that CM practitioners recommended a GFD for included skin 116 
conditions (60%), children with developmental disorders (53%), mental health conditions 117 
(46%), weight management (39%) and neurological conditions (33%). A summary of all extra-118 
intestinal conditions a GFD was recommended for can be seen in Table 3.  119 
Significant medium associations were found between level of qualification and CM 120 
practitioners who prescribed a GFD diet for skin conditions (p=0,036) and weight management 121 
(p=0.09). Practitioners who had a bachelor degree or higher were more likely to recommend 122 
a GFD for skin conditions or for weight management than those with a lower qualification. 123 
Similarly, a significant medium association was found between length of time in practice and 124 
prescription of a GFD for auto-immune disease (p=0.025); the longer the practitioner was in 125 
practice the more likely they were to recommend a GFD for auto-immune diseases (See Table 126 
3). 127 
INSERT TABLE 3 128 
 129 
Patient communication with CMPs about GFDs 130 
 131 
When practitioners were asked if patients enquired about a GFD they reported that the 132 
majority of patients wanted to know their opinion on the benefits of a GFD (n=110, 78%). A 133 
greater number of patients were found to be following a GFD prior to consulting a CMP (n=82: 134 
57.7%) compared to those who were not (n=60: 42.3%; see Table 4) 135 
No statistical difference was found between people who have been medically diagnosed with 136 
CD and patients who ask CM practitioners opinion on the benefits of GF diet (p=0.51). 137 
Likewise, no statistical difference was found with CM practitioners who personally follow a GF 138 
diet and patients asking them about the benefits of a GFD (p=0.81), or between CM 139 
practitioners who refer to medical practitioners or specialists and how often people ask for 140 
their opinion on the benefits of a GFD (p=0.855).   141 
INSERT TABLE 4 142 
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Discussion 143 
The aim of this study was to describe for what health conditions Australian naturopaths, 144 
Western herbalists and nutritionists (non-dietetic) recommend a gluten free diet. This study 145 
found that the range of conditions, including extra-intestinal conditions, for which CMPs 146 
recommend GFDs is diverse. The extent of therapeutic benefit obtained from such 147 
recommendations is unknown, which is an important area for future research.  148 
 149 
GFDs are essential for patients with coeliac disease, gluten ataxia, dermatitis herpetiformis 150 
and wheat allergy, and provide relief for those with NCGS [8-10]. However, this study has 151 
revealed that CMPs are recommending GFDs for a much broader range of health conditions. 152 
In addition to the conditions with a medical indication for a GFD, CMPs recommend a GFD to 153 
people living with inflammatory bowel disease, irritable bowel syndrome, non-specific 154 
gastrointestinal symptoms such as bloating and flatulence, people with chronic constipation, 155 
and a number of extra-intestinal conditions. The published evidence to support such a 156 
recommendation currently is lacking.  157 
 158 
The results of this investigation are valuable for a number of reasons. First, given the broader 159 
clinical application, it could be implied that GFDs are playing a therapeutic role in the 160 
management of a number of conditions other than those with established evidence for dietary 161 
exclusion of gluten. These recommendations from qualified practitioners are likely to occur if 162 
both practitioner and their patients are observing some therapeutic gain. Therefore, this opens 163 
up an opportunity for future research to conduct clinical trials or observation studies to confirm 164 
or deny this benefit. Consequently, this study has also identified a need for research that 165 
evaluates the therapeutic outcomes of GFDs across a broader range of health conditions. 166 
Especially those conditions or symptoms that CMPs are most commonly recommending GFDs 167 
for including; inflammatory bowel disease, bloating and flatulence, irritable bowel syndrome, 168 
chronic constipation, skin conditions, and children with developmental disorders. 169 
 170 
A recent study on NCGS investigated a new theory on possible pathogenic mechanisms [14]. 171 
This study considered that NCGS was a multi-factor-onset disorder, which can be potentially 172 
transient and preventable without a specific genetic pattern. There is a possibility of an 173 
epigenetic component which can be strongly related to diet and the microbiotia. Therefore, 174 
dietary choices, dysbiosis, short chain fatty acid production and possibility intestinal 175 
permeability may all be involved with NCGS [14].  176 
 177 
A critical point that cannot be ignored here is the potential that any benefits obtained from a 178 
GFD for symptoms or conditions, are not in fact associated with an established gluten related 179 
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disorder and may be related to intolerance to fermentable carbohydrates. The removal of 180 
gluten from the diet may be inadvertently be treating an undiagnosed gluten related disorder 181 
or carbohydrate intolerance. It is important that any common co-morbidity or symptoms of a 182 
gluten related disorder is fully investigated consistent with established evidence-based clinical 183 
guidelines [15]. In addition, symptoms of bloating, flatulence and irritable bowel syndrome 184 
have been associated with an intolerance to short-chain carbohydrates [16]. Patients with an 185 
intolerance to short chain carbohydrates including fermentable oligosaccharides, 186 
disaccharides, monosaccharaides and polyols (FODMAPs) respond to excluding FODMAP 187 
containing foods; excluding FODMAP containing foods does not necessitate an exclusion of 188 
all gluten containing grains, only wheat [17]. Whilst long term exclusion of FODMAP containing 189 
foods has been associated with alterations in the microbiome, the consequences of these 190 
changes are still being elucidated. There are implications for dietary exclusion of gluten; for 191 
example, nutritional deficiencies have been identified in people with CD who adhered to a 192 
GFD; however, this is likely to be related to inadequate dietary choices and/or poor recovery 193 
of the absorptive surface of the small intestine [18]. 194 
 195 
Overall, this study raises more questions than it answers, and reveals numerous areas for 196 
further research. It is important to note that the findings of this study are limited by the sample 197 
size (n=145) and potentially by the selection of practitioners registered with PRACI or the 198 
professional organisations. Furthermore, whilst the range of conditions for which a GFD was 199 
recommended was broad, no insights as to the basis of GFD use for these other conditions 200 
was either requested or provided. Consequently, as mentioned, there is no evidence to date 201 
to demonstrate whether the broader recommendation of a GFD is a fad or in fact an important 202 
dietary intervention for a number of conditions other than those with a known medical 203 
indication. Further research to investigate the effects of such recommendations is required.  204 
 205 
Conclusion 206 
This study has identified that CMPs are recommending a GFD for a broad number of health 207 
conditions in addition to those with a medical indication for this dietary restriction; including 208 
inflammatory bowel disease, irritable bowel syndrome, non-specific gastrointestinal symptoms 209 
(e.g. bloating and flatulence), chronic constipation and various extra-intestinal conditions. 210 
There is currently no strong evidence to support the benefits of a GFD for these; thus providing 211 
opportunities for future research. Future research is also needed to determine the reasons 212 
why CMPs recommend GFDs in conditions for which it is not indicated. 213 
 214 
  215 
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